Earnings NewsHealthcareKaryopharm Therapeutics Q2 2022 Earnings PreviewAug. 03, 2022 12:28 PM ETKaryopharm Therapeutics Inc. (KPTI)By: Pranav Ghumatkar, SA News Editor Karyopharm Therapeutics (NASDAQ:KPTI) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open. The consensus EPS Estimate is -$0.64 (+9.9% Y/Y) and the consensus Revenue Estimate is $35.96M (+59.1% Y/Y). Over the last 3 months, EPS estimates have seen 4 upward revisions and 4 downward. Revenue estimates have seen 2 upward revisions and 4 downward. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.